Literature DB >> 6323129

Thyrotropin-stimulated iodide transport mediated by adenosine 3',5'-monophosphate and dependent on protein synthesis.

S J Weiss, N J Philp, F S Ambesi-Impiombato, E F Grollman.   

Abstract

Iodide (I-) uptake by FRTL-5 cells, a functioning rat thyroid cell line, is TSH dependent. The effects of TSH withdrawal are not apparent until 1 day; 1 week is required to reduce I- uptake to a minimal level. The readdition of TSH leads to a return of the I--concentrating ability after a latency of 12-24 h. The reappearance of I- uptake induced by TSH is mimicked by (Bu)2cAMP and agents that elevate intracellular cAMP levels in these cells, such as forskolin, cholera toxin, and a Graves' disease serum. The appearance of I- uptake after TSH occurs 12 h after the appearance of TSH-induced [35S]methionine incorporation. Cycloheximide blocks both the TSH- and (Bu)2cAMP-induced increases in methionine incorporation and I- uptake to the same extent and in an identical concentration-dependent manner. TSH-induced [35S]methionine incorporation is associated with increased radiolabeling of several specific proteins, as revealed by gel electrophoresis; none, however, is radiolabeled coincident in time with the appearance of TSH-induced I- uptake. Several proteins whose apparent synthesis is induced by TSH also exhibit TSH-dependent phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323129     DOI: 10.1210/endo-114-4-1099

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  26 in total

Review 1.  Regulation of sodium/iodide symporter.

Authors:  S M Jhiang
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Decreased radioiodine uptake of FRTL-5 cells after (131)I incubation in vitro: molecular biological investigations indicate a cell cycle-dependent pathway.

Authors:  Birgit Meller; Erzsébet Gaspar; Wibke Deisting; Barbara Czarnocka; Manfred Baehre; Björn E Wenzel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-29       Impact factor: 9.236

3.  Thyrotropin upregulates alpha 1-adrenergic receptors in rat FRTL-5 thyroid cells.

Authors:  D Corda; L D Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

4.  Activation of the beta 2-adrenergic receptor promotes growth and differentiation in thyroid cells.

Authors:  R Hen; R Axel; S Obici
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells.

Authors:  Sasha Beyer; Aparna Lakshmanan; Yu-Yu Liu; Xiaoli Zhang; Irene Wapnir; Albert Smolenski; Sissy Jhiang
Journal:  Endocrinology       Date:  2011-01-05       Impact factor: 4.736

6.  Analysis of cellular localization and function of carboxy-terminal mutants of pendrin.

Authors:  Aigerim Bizhanova; Teng-Leong Chew; Satya Khuon; Peter Kopp
Journal:  Cell Physiol Biochem       Date:  2011-11-16

7.  TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells.

Authors:  Liuska Pesce; Aigerim Bizhanova; Juan Carlos Caraballo; Whitney Westphal; Maria L Butti; Alejandro Comellas; Peter Kopp
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

8.  Identification of cyclic adenosine 3',5'-monophosphate response element modulator as an activator of the human sodium/iodide symporter upstream enhancer.

Authors:  Mike S Fenton; Kenneth M Marion; Jerome M Hershman
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

9.  Thyroid-specific enhancer-binding protein (T/EBP): cDNA cloning, functional characterization, and structural identity with thyroid transcription factor TTF-1.

Authors:  K Mizuno; F J Gonzalez; S Kimura
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

10.  Theophylline increases the uptake of radioiodine by mouse thyroid.

Authors:  Jong Min Lee; Patrizio Caturegli; Paul W Ladenson
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.